Loader

Pathways

PathWhiz ID Pathway Meta Data

PW145155

Pw145155 View Pathway
drug action

Acetophenazine Drug Metabolism Action Pathway

Homo sapiens

PW124173

Pw124173 View Pathway
metabolic

acetyl CoA production by PDH and Krebs cycle

human
metabolic pathway of acetyl CoA production by PDH and Krebs cycle

PW128457

Pw128457 View Pathway
drug action

Acetyl sulfisoxazole Action Pathway

Escherichia coli (strain K12)
Acetyl sulfisoxazole is an antibacterial from the sulfanilamide drug class. It is a broad-spectrum antibiotic indicated against urinary tract infections, meningococcal meningitis, acute otitis media, inclusion conjunctivitis, toxoplasmosis, and many others. Acetyl sulfisoxazole is a synthetic bacteriostatic, meaning that it stops the bacteria from growing. This drug binds competitively to the dihydropteroate synthase enzyme. This enzyme is essential to produce dihydrofolic acid in bacteria, when it is inhibited, the bacteria cannot grow anymore because they cannot produce DNA with the folic acid. Thus drug is administered as an oral tablet. N1-acetyl sulfisoxazole is metabolized to sulfisoxazole by digestive enzymes in the gastrointestinal tract and is absorbed as sulfisoxazole (the active compound).

PW132441

Pw132441 View Pathway
metabolic

Acetyl sulfisoxazole Drug Metabolism

Homo sapiens
Acetyl sulfisoxazole is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Acetyl sulfisoxazole passes through the liver and is then excreted from the body mainly through the kidney.

PW146741

Pw146741 View Pathway
drug action

Acetyl sulfisoxazole Drug Metabolism Action Pathway

Homo sapiens

PW120684

Pw120684 View Pathway
protein

Acetylation and Deacetylation of RelA in The Nucleus

Homo sapiens
NF-kB transcription factor plays a role in the inflammatory and immune response of mammals. Acetylation of RelA regulates NF-kB activity. Tumor necrosis factor activates tumor necrosis factor receptor, recruiting proteins FADD, TRADD, RIP and TRAF6 to activate the NF-kB pathway. Activation of IKK complex causes the phosphorylation of I-kappa-B-alpha and triggers its degradation. I-kappa-B-alpha normally sequesters KF-kB in the cytoplasm, following its degradation, RELA and p50 (subunits of NF-kB) are liberated can translocate to the nucleus to activate gene expression. RelA and p50 associate with p300 and CREB transcriptional co-activators causing the acetylation of RelA and increase in transcriptional activity. Acetylated RelaA is targeted for deacetylation by transcriptional co-repressor Histone deacetylation 3 (HDAC3). This promotes its binding to I-kappa-B-alpha causing NF-kB's transport out of the nucleus and reduces its activity.

PW145852

Pw145852 View Pathway
drug action

Acetylcarnitine Drug Metabolism Action Pathway

Homo sapiens

PW145524

Pw145524 View Pathway
drug action

Acetylcholine Drug Metabolism Action Pathway

Homo sapiens

PW123915

Pw123915 View Pathway
signaling

acetylcholine signaling

Rattus norvegicus

PW145663

Pw145663 View Pathway
drug action

Acetylcysteine Drug Metabolism Action Pathway

Homo sapiens